Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)09844TORECAN obalené tablety 6,5 mg (tbl obd 50x6,5 mg (fľ.skl.jant.))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)23105Helex SR 2 mg (tbl mod 30x2 mg (blis.OPA/Al/PVC/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)30031Doreta 75 mg/650 mg filmom obalené tablety (tbl flm 60x75 mg/650 mg (blis.PVC/PVDC/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)30403Dasselta 5 mg filmom obalená tableta (tbl flm 50x5 mg (blis.OPA/Al/PVC/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)3487BArisppa 15 mg tablety (tbl 60x15 mg (blis.OPA/Al/PVC/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)3516CAdolax 10 mg/5 mg (tbl plg 60x1x10 mg/5 mg (blis.PVC/PVDC/PET/Al-jednotliv.bal.))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)3535ACoryol 25 (tbl 90x25 mg (blis.OPA/Al/PVC/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)53283FROMILID 500 (tbl flm 14x500 mg (blis.PVC/PVDC/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)64182RAWEL SR (tbl plg 90x1,5 mg (blister PVC/PVDc/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)6519BDoreta SR 75 mg/650 mg tablety s predĺženým uvoľňovaním (tbl plg 30x75 mg/650 mg (blis.PVC/PVDC/papier/Al))23.12.2024R
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)3023BKventiax SR 200 mg tablety s predĺženým uvoľňovaním (tbl plg 60x200 mg (blis.OPA/Al/PVC/Al))23.12.2024O
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)4386BLoxentia 40 mg tvrdé gastrorezistentné kapsuly (cps end 56x40 mg (blis.OPA/Al/[HDPE/PE+DES z CaO/HDPE]/Al/PE))23.12.2024O
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)45768Zalasta 15 mg orodispergovateľné tablety (tbl oro 70x15 mg)23.12.2024O
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)8025AOprymea 0,26 mg tablety s predĺženým uvoľňovaním (tbl plg 30x0,26 mg (blis.OPA/Al/vysušovadlo/PE/Al))23.12.2024O
 20.12.2024KRKA, d.d., Novo mesto (KRK-2)9535DCo-Prenessa Neo 5 mg/1,25 mg tablety (tbl 90x5 mg/1,25 mg (blis.OPA/Al/PVC//Al))23.12.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)